FDA Review of Varenicline and Risk of Cardiovascular Adverse Events

DECEMBER 19, 2012
This podcast, from the Centers for Disease Control and Prevention, discusses a drug safety communication released by the FDA on December 12, 2012, regarding the risk of cardiovascular adverse events associated with the smoking-cessation drug varenicline (Chantix).
 
To download the podcast, click .

SHARE THIS
0
Plantsvszombies.info Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs

http://steroid-pharm.com

www.pharmacy24.com.ua

https://buysteroids.in.ua